[ad_1] The European Commission has approved a supply contract with US firm Novavax to buy up to 200 million doses of its potential COVID-19 vaccine, Report informs, citing Reuters. The move is part of the EU’s strategy to diversify its vaccine portfolio after the bloc betted heavily for the coming years on messenger RNA (mRNA)… Continue reading EU inks deal with Novavax for up to 200 million COVID shots